These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27376664)

  • 1. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA
    J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
    Al-Hasan MN; Wilson JW; Lahr BD; Thomsen KM; Eckel-Passow JE; Vetter EA; Tleyjeh IM; Baddour LM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1386-94. PubMed ID: 19164144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study.
    Deelen JWT; Rottier WC; Buiting AGM; Dorigo-Zetsma JW; Kluytmans JAJW; van der Linden PD; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Ammerlaan HSM; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2021 Feb; 27(2):269-275. PubMed ID: 32387438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.
    Tamma PD; Turnbull AE; Harris AD; Milstone AM; Hsu AJ; Cosgrove SE
    JAMA Pediatr; 2013 Oct; 167(10):903-10. PubMed ID: 23921724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
    Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Kollef MH
    Antimicrob Agents Chemother; 2010 May; 54(5):1742-8. PubMed ID: 20160050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
    Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
    Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Fluoroquinolones and the Risk of Uveitis.
    Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
    JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patients.
    Wade WE; McCall CY
    Pharmacotherapy; 1995; 15(2):216-9. PubMed ID: 7624269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycosides versus beta-lactams in gram-negative pneumonia.
    Collins T; Gerding DN
    Semin Respir Infect; 1991 Sep; 6(3):136-46. PubMed ID: 1754734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?
    Ondrusova A; Grey E; Benca J; Rudinsky B; Huttova M; Bauer F; Kovac M; Sramka M
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():17-8. PubMed ID: 17558368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
    Wilson BZ; Anzueto A; Restrepo MI; Pugh MJ; Mortensen EM
    Crit Care Med; 2012 Aug; 40(8):2310-4. PubMed ID: 22622401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Treatment Failure Following De-escalation to a Fluoroquinolone in Culture-Negative Nosocomial Pneumonia.
    Bultas AC; Bery AI; Deal EN; Hartmann AP; Richter SK; Call WB
    Ann Pharmacother; 2019 Dec; 53(12):1207-1213. PubMed ID: 31347400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.